John David Hansen

This profile gathers the share dealings of John David Hansen in Mabvax Therapeutics Holdings, Inc. Between 4 April 2016 and 2 April 2018, the trades on record add up to 20 filings.

Both buying and selling appear: 3 purchases worth €6,749, against 11 sales worth €233k. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants and 4 option exercises. So far in 2018, the count stands at no purchases and 4 sales.

The record was last updated on 3 April 2018 with an option exercise in Mabvax Therapeutics Holdings, Inc. The most recent open-market purchase was published on 2 August 2017, 3,366 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.